The study design and rationale of the randomized controlled trial: Translating COPD guidelines into primary care practice

Donna Parker, Charles B. Eaton, David K. Ahern, Mary B. Roberts, Caitlin Rafferty, Roberta E. Goldman, F. Dennis McCool, Joseph Wroblewski

Research output: Contribution to journalArticle

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disease associated with significant clinical burden and is estimated to affect 15 million individuals in the US. Although a large number of individuals are diagnosed with COPD, many individuals still remain undiagnosed due to the slow progression of the disorder and lack of recognition of early symptoms. Not only is there under-diagnosis but there is also evidence of sub-optimal evidence-based treatment of those who have COPD. Despite the development of international COPD guidelines, many primary care physicians who care for the majority of patients with COPD are not translating this evidence into effective clinical practice. Method/Design. This paper describes the design and rationale for a randomized, cluster design trial (RCT) aimed at translating the COPD evidence-based guidelines into clinical care in primary care practices. During Phase 1, a needs assessment evaluated barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from focus groups, three tools were developed. These include a computerized patient activation tool (an interactive iPad with wireless data transfer to the spirometer); a web-based COPD guideline tool to be used by primary care providers as a decision support tool; and a COPD patient education toolkit to be used by the practice team. During phase II, an RCT will be performed with one year of intervention within 30 primary care practices. The effectiveness of the materials developed in Phase I are being tested in Phase II regarding physician performance of COPD guideline implementation and the improvement in the clinically relevant outcomes (appropriate diagnosis and management of COPD) compared to usual care. We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. Discussion. Using a multi-modal intervention of patient activation and a technology-supported health care provider team, we are testing the effectiveness of this intervention in activating patients and improving physician performance around COPD guideline implementation. Trial registration. ClinicalTrials.gov, NCT01237561.

Original languageEnglish (US)
Article number56
JournalBMC Family Practice
Volume14
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Primary Health Care
Randomized Controlled Trials
Guidelines
Patient Participation
Focus Groups
Practice (Psychology)
Physicians
Patient Care Team
Needs Assessment
Spirometry
Primary Care Physicians
Smoking Cessation
Patient Education
Health Personnel
Patient Care
Technology

Keywords

  • COPD
  • Guidelines
  • Primary care
  • Randomized Clinical Trial

ASJC Scopus subject areas

  • Family Practice

Cite this

The study design and rationale of the randomized controlled trial : Translating COPD guidelines into primary care practice. / Parker, Donna; Eaton, Charles B.; Ahern, David K.; Roberts, Mary B.; Rafferty, Caitlin; Goldman, Roberta E.; McCool, F. Dennis; Wroblewski, Joseph.

In: BMC Family Practice, Vol. 14, 56, 2013.

Research output: Contribution to journalArticle

Parker, Donna ; Eaton, Charles B. ; Ahern, David K. ; Roberts, Mary B. ; Rafferty, Caitlin ; Goldman, Roberta E. ; McCool, F. Dennis ; Wroblewski, Joseph. / The study design and rationale of the randomized controlled trial : Translating COPD guidelines into primary care practice. In: BMC Family Practice. 2013 ; Vol. 14.
@article{9b17dd4cd1484442bf600252f3b32094,
title = "The study design and rationale of the randomized controlled trial: Translating COPD guidelines into primary care practice",
abstract = "Background: Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disease associated with significant clinical burden and is estimated to affect 15 million individuals in the US. Although a large number of individuals are diagnosed with COPD, many individuals still remain undiagnosed due to the slow progression of the disorder and lack of recognition of early symptoms. Not only is there under-diagnosis but there is also evidence of sub-optimal evidence-based treatment of those who have COPD. Despite the development of international COPD guidelines, many primary care physicians who care for the majority of patients with COPD are not translating this evidence into effective clinical practice. Method/Design. This paper describes the design and rationale for a randomized, cluster design trial (RCT) aimed at translating the COPD evidence-based guidelines into clinical care in primary care practices. During Phase 1, a needs assessment evaluated barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from focus groups, three tools were developed. These include a computerized patient activation tool (an interactive iPad with wireless data transfer to the spirometer); a web-based COPD guideline tool to be used by primary care providers as a decision support tool; and a COPD patient education toolkit to be used by the practice team. During phase II, an RCT will be performed with one year of intervention within 30 primary care practices. The effectiveness of the materials developed in Phase I are being tested in Phase II regarding physician performance of COPD guideline implementation and the improvement in the clinically relevant outcomes (appropriate diagnosis and management of COPD) compared to usual care. We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. Discussion. Using a multi-modal intervention of patient activation and a technology-supported health care provider team, we are testing the effectiveness of this intervention in activating patients and improving physician performance around COPD guideline implementation. Trial registration. ClinicalTrials.gov, NCT01237561.",
keywords = "COPD, Guidelines, Primary care, Randomized Clinical Trial",
author = "Donna Parker and Eaton, {Charles B.} and Ahern, {David K.} and Roberts, {Mary B.} and Caitlin Rafferty and Goldman, {Roberta E.} and McCool, {F. Dennis} and Joseph Wroblewski",
year = "2013",
doi = "10.1186/1471-2296-14-56",
language = "English (US)",
volume = "14",
journal = "BMC Family Practice",
issn = "1471-2296",
publisher = "BioMed Central",

}

TY - JOUR

T1 - The study design and rationale of the randomized controlled trial

T2 - Translating COPD guidelines into primary care practice

AU - Parker, Donna

AU - Eaton, Charles B.

AU - Ahern, David K.

AU - Roberts, Mary B.

AU - Rafferty, Caitlin

AU - Goldman, Roberta E.

AU - McCool, F. Dennis

AU - Wroblewski, Joseph

PY - 2013

Y1 - 2013

N2 - Background: Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disease associated with significant clinical burden and is estimated to affect 15 million individuals in the US. Although a large number of individuals are diagnosed with COPD, many individuals still remain undiagnosed due to the slow progression of the disorder and lack of recognition of early symptoms. Not only is there under-diagnosis but there is also evidence of sub-optimal evidence-based treatment of those who have COPD. Despite the development of international COPD guidelines, many primary care physicians who care for the majority of patients with COPD are not translating this evidence into effective clinical practice. Method/Design. This paper describes the design and rationale for a randomized, cluster design trial (RCT) aimed at translating the COPD evidence-based guidelines into clinical care in primary care practices. During Phase 1, a needs assessment evaluated barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from focus groups, three tools were developed. These include a computerized patient activation tool (an interactive iPad with wireless data transfer to the spirometer); a web-based COPD guideline tool to be used by primary care providers as a decision support tool; and a COPD patient education toolkit to be used by the practice team. During phase II, an RCT will be performed with one year of intervention within 30 primary care practices. The effectiveness of the materials developed in Phase I are being tested in Phase II regarding physician performance of COPD guideline implementation and the improvement in the clinically relevant outcomes (appropriate diagnosis and management of COPD) compared to usual care. We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. Discussion. Using a multi-modal intervention of patient activation and a technology-supported health care provider team, we are testing the effectiveness of this intervention in activating patients and improving physician performance around COPD guideline implementation. Trial registration. ClinicalTrials.gov, NCT01237561.

AB - Background: Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating disease associated with significant clinical burden and is estimated to affect 15 million individuals in the US. Although a large number of individuals are diagnosed with COPD, many individuals still remain undiagnosed due to the slow progression of the disorder and lack of recognition of early symptoms. Not only is there under-diagnosis but there is also evidence of sub-optimal evidence-based treatment of those who have COPD. Despite the development of international COPD guidelines, many primary care physicians who care for the majority of patients with COPD are not translating this evidence into effective clinical practice. Method/Design. This paper describes the design and rationale for a randomized, cluster design trial (RCT) aimed at translating the COPD evidence-based guidelines into clinical care in primary care practices. During Phase 1, a needs assessment evaluated barriers and facilitators to implementation of COPD guidelines into clinical practice through focus groups of primary care patients and providers. Using formative evaluation and feedback from focus groups, three tools were developed. These include a computerized patient activation tool (an interactive iPad with wireless data transfer to the spirometer); a web-based COPD guideline tool to be used by primary care providers as a decision support tool; and a COPD patient education toolkit to be used by the practice team. During phase II, an RCT will be performed with one year of intervention within 30 primary care practices. The effectiveness of the materials developed in Phase I are being tested in Phase II regarding physician performance of COPD guideline implementation and the improvement in the clinically relevant outcomes (appropriate diagnosis and management of COPD) compared to usual care. We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. Discussion. Using a multi-modal intervention of patient activation and a technology-supported health care provider team, we are testing the effectiveness of this intervention in activating patients and improving physician performance around COPD guideline implementation. Trial registration. ClinicalTrials.gov, NCT01237561.

KW - COPD

KW - Guidelines

KW - Primary care

KW - Randomized Clinical Trial

UR - http://www.scopus.com/inward/record.url?scp=84877029149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877029149&partnerID=8YFLogxK

U2 - 10.1186/1471-2296-14-56

DO - 10.1186/1471-2296-14-56

M3 - Article

C2 - 23641803

AN - SCOPUS:84877029149

VL - 14

JO - BMC Family Practice

JF - BMC Family Practice

SN - 1471-2296

M1 - 56

ER -